Profil
Michael Dambach currently works at Reata Pharmaceuticals, Inc., as Director from 2023.
Postes actifs de Michael Dambach
| Sociétés | Poste | Début |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | Director/Board Member | 26/09/2023 |
Expériences
Fonctions occupées
Relations
26
Relations au 1er degré
1
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
